Stock Scorer

Pfizer Inc (PFE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 10B 20B 30B Q4 '21: 24B Q4 '21: 16.2B Q2 '22: 25.7B Q3 '22: 27.7B Q4 '22: 22.6B Q4 '22: 15.8B Q2 '23: 18.5B Q3 '23: 13B Q4 '23: 13.5B Q4 '23: 14.6B Q1 '24: 14.9B Q2 '24: 13.3B Q3 '24: 17.7B Q4 '24: 17.8B Q1 '25: 13.7B Q2 '25: 14.7B Q3 '25: 16.7B Q4 '25: 17.6B Q1 '26: 14.5B Q2 '26: 15B Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 7B 14B 21B Q4 '21: 14.1B Q4 '21: 6.5B Q2 '22: 15.7B Q3 '22: 19.1B Q4 '22: 16.6B Q4 '22: 6.1B Q2 '23: 13.6B Q3 '23: 9.8B Q4 '23: 4.2B Q4 '23: 7B Q1 '24: 11.5B Q2 '24: 10B Q3 '24: 12.4B Q4 '24: 11.9B Q1 '25: 10.9B Q2 '25: 10.9B Q3 '25: 12.5B Q4 '25: 12.3B Q1 '26: 10.9B Q2 '26: 10.9B Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Net Income Quarterly

-3.5B 0 3.5B 7B 10.5B Q3 '21: 5.6B Q4 '21: 8.1B Q4 '21: 3.4B Q2 '22: 7.9B Q3 '22: 9.9B Q4 '22: 8.6B Q4 '22: 5B Q2 '23: 5.5B Q3 '23: 2.3B Q4 '23: -2.4B Q4 '23: -3.4B Q1 '24: 3.1B Q2 '24: 41M Q3 '24: 4.5B Q4 '24: 410M Q1 '25: 3B Q2 '25: 2.9B Q3 '25: 3.5B Q1 '26: 2.7B Q2 '26: -248M Q4 '21 Q3 '22 Q2 '23 Q4 '23 Q3 '24 Q2 '25 Q2 '26

Cost of Revenue Quarterly

0 3.5B 7B 10.5B Q4 '21: 9.9B Q4 '21: 9.7B Q2 '22: 10B Q3 '22: 8.6B Q4 '22: 6.1B Q4 '22: 9.6B Q2 '23: 4.9B Q3 '23: 3.2B Q4 '23: 9.3B Q4 '23: 7.6B Q1 '24: 3.4B Q2 '24: 3.3B Q3 '24: 5.3B Q4 '24: 5.9B Q1 '25: 2.8B Q2 '25: 3.8B Q3 '25: 4.2B Q4 '25: 5.3B Q1 '26: 3.5B Q2 '26: 4.1B Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-4B 0 4B 8B 12B Q4 '21: 10.8B Q4 '21: 5.9B Q2 '22: 6.5B Q3 '22: 8.2B Q4 '22: 6B Q4 '22: 8.6B Q2 '23: 1.2B Q3 '23: -1.2B Q4 '23: 3.5B Q4 '23: 5.2B Q1 '24: 1.1B Q2 '24: -1.8B Q3 '24: 6.7B Q4 '24: 6.7B Q1 '25: 2.3B Q2 '25: -582M Q3 '25: 4.6B Q4 '25: 5.3B Q1 '26: 2.6B Q2 '26: 835M Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-3.5B 0 3.5B 7B 10.5B Q4 '21: 10.2B Q4 '21: 4.9B Q2 '22: 5.9B Q3 '22: 7.4B Q4 '22: 5.1B Q4 '22: 7.6B Q2 '23: 73M Q3 '23: -2.1B Q4 '23: 2.6B Q4 '23: 4.2B Q1 '24: 386M Q2 '24: -2.4B Q3 '24: 6.1B Q4 '24: 5.8B Q1 '25: 1.8B Q2 '25: -1.2B Q3 '25: 4B Q4 '25: 4.5B Q1 '26: 2.2B Q2 '26: 302M Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 2B 4B 6B Q1 '20: 5.6B Q2 '20: 5.6B Q3 '20: 5.6B Q2 '21: 5.7B Q3 '21: 5.7B Q4 '21: 5.7B Q2 '22: 5.8B Q3 '22: 5.7B Q4 '22: 5.7B Q2 '23: 5.7B Q3 '23: 5.7B Q4 '23: 5.6B Q1 '24: 5.7B Q2 '24: 5.7B Q3 '24: 5.7B Q1 '25: 5.7B Q2 '25: 5.7B Q3 '25: 5.7B Q1 '26: 5.7B Q2 '26: 5.7B Q2 '20 Q3 '21 Q3 '22 Q3 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.00 0.00 2.00 4.00 6.00 Q4 '20: 1.63 Q2 '21: 1.89 Q3 '21: 2.25 Q4 '21: 3.41 Q4 '21: 3.84 Q2 '22: 4.35 Q3 '22: 5.10 Q4 '22: 5.19 Q4 '22: 5.48 Q2 '23: 5.08 Q3 '23: 3.76 Q4 '23: 1.83 Q4 '23: 0.37 Q1 '24: -0.05 Q2 '24: -0.45 Q3 '24: 0.75 Q4 '24: 1.41 Q1 '25: 1.38 Q2 '25: 1.88 Q3 '25: 1.72 Q2 '21 Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for PFE: Operating Income. Nothing in this filer's XBRL supports it for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.